Skip to main content

PERSPECTIVE article

Front. Nephrol.
Sec. Clinical Research in Nephrology
Volume 4 - 2024 | doi: 10.3389/fneph.2024.1455260

Proceedings of a Membrane Update Symposium: Advancements, Scientific Insights, and Future Trends for Dialysis Membranes for Enhanced Clinical Outcomes in End Stage Kidney Disease Patients

Provisionally accepted
  • 1 University of Würzburg, Department of Clinical Research and Epidemiology, Renal Research Unit, Würzburg, Germany, Würzburg, Bavaria, Germany
  • 2 Nephrology Section, Department of Internal Medicine and Pediatrics, University Hospital, Ghent, Belgium
  • 3 Other, Brussels, Belgium
  • 4 Other, Madrid, Spain
  • 5 UCL Department of Nephrology, Royal Free Hospital, University College London, Rowland Hill Street, London, United Kingdom
  • 6 Université de Montpellier, Montpellier, France
  • 7 Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands, Netherlands
  • 8 Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Sciences, Utrecht University, Utrecht, Netherlands, Netherlands
  • 9 Division of Nephrology, Department of Internal Medicine, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands, Netherlands
  • 10 Department of Internal Medicine, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, Netherlands
  • 11 Department of Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • 12 Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
  • 13 Advanced Organ Bioengineering and Therapeutics-Technical Medical Centre, University of Twente, Enschede, Netherlands
  • 14 Department of Nephrology- Radboud university medical center, Radboud institute for molecular life sciences, Geert Grooteplein 10, Nijmegen, Netherlands
  • 15 Other, Manchester, United Kingdom
  • 16 Other, Amsterdam, Netherlands
  • 17 Amsterdam Cardiovascular Sciences, Diabetes & Metabolism, Amsterdam, Netherlands
  • 18 Other, Krems, Austria
  • 19 Medical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany
  • 20 Department of Chemical and Biological Engineering, Division of Biomedical Engineering, University of Saskatchewan, Sakatoon, Canada
  • 21 Other, Bad Homburg, Germany
  • 22 Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet (KI), Huddinge, Sweden

The final, formatted version of the article will be published soon.

    Purpose of Symposium: From September 6 -8 2022, the Life/2022 Membrane Symposium was held in Frankfurt, Germany, and transmitted live to a worldwide internet audience. The event was part of the Life/Nephrology Campus initiative, a continuous educational platform for the nephrology community to expand knowledge and share expertise on contemporary topics in chronic kidney disease. We describe recent questions and advances in the field, and we underline challenges in the care of dialysis patients and opportunities for integration of new findings into clinical practice to improve patient outcomes in end stage kidney disease patients.Topics: Most patients with kidney failure are on maintenance hemodialysis (MHD). The scientific program of the symposium was developed around topics about the role, functional determinants, technical aspects, limitations, and clinical implications of membranes presently in use. International experts with clinical or technical expertise as well as scientific recognition within the nephrology community were asked to prepare their presentations based on their own experiences, perceptions, opinions, and sources of information.The symposium devoted a major portion to discussing novel approaches for improving membranes and treatment quality, including updates on innovative concepts that may could potentially transform the landscape of kidney replacement therapy for chronic kidney disease patients in the future.

    Keywords: Dialysis membranes1, innovation2, Biocompatibility3, Science4, technology5, Clinical impact6, Chronic kidney disease7

    Received: 26 Jun 2024; Accepted: 04 Sep 2024.

    Copyright: © 2024 Wanner, Vanholder, Ortiz, Davenport, Canaud, Blankestijn, Masereeuw, Kooman, Castellano, Stamatialis, Mitra, Grooteman, Weber, Ebert, Abdelrasoul, Steppan, Scheiwe and Stenvinkel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Anna R. Scheiwe, Other, Bad Homburg, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.